Abstract
Background Vascular limb salvage services can potentially improve outcomes for patients with chronic limb threatening ischaemia (CLTI) and/or diabetic foot ulceration (DFU). This study aims to evaluate the early outcomes for a vascular limb salvage (VaLS) clinic and investigate times-to-treatment.
Methods A retrospective analysis involving all patients diagnosed with CLTI/DFU within the VaLS clinic from February 2018-February 2019 was undertaken. Data were compared to two comparator cohorts; patients managed prior to the clinic, between May 2017-February 2018 (Pre-Clinic’ (PC)), and patients managed outside of clinic, between February 2018-February 2019 (‘Alternative Pathways’ (AP)). Major amputation at 12 months was the primary outcome. Kaplan-Meier survival analysis and adjusted Cox’s proportional hazard models were utilised to compare outcomes.
Results Six-hundred and forty-six patients (VaLS=200, PC=252, AP=194) were included (median age=73 years, median follow-up=365 days). Within the VaLS clinic, patients underwent assessment within a median of 2.1[IQR 1.3-3.1] days from referral. No differences in median time from assessment to treatment were identified (VaLS=6.1[3.9-11.1] vs. AP=5.7[2.6-12.9] days, p=.394; VaLS vs. PC=6.1[2.8-22.8] days, p=.888). The VaLS cohort had a significantly lower rate of major amputation at 12 months (9.5%) compared to both the AP (19.6%, aHR 0.42, 95% CI 0.24-0.74, p=.003) and the PC (19.4%; aHR 0.45, 95% CI 0.27-0.78, p=.004) cohorts, after adjustment for potential confounding.
Conclusions A limb salvage clinic can help reduce the rate of major amputation and provides a model which delivers timely vascular assessment. Whilst early outcomes are promising, further evaluation is required to assess longer-term outcomes and reduce time-to-treatment.
Competing Interest Statement
RSMD has received personal fees for speaking from Cook Medical and Gore, and has received sponsorship from TerumoAortic to run educational workshops. These are outside of the submitted work. The other authors have nothing to declare
Funding Statement
ATON, JD, LR, SD, HL, JSMH, SN and TP are funded through the George Davies Charitable Trust (Registered Charity Number: 1034818). RDS is part funded through this Trust. The funders had no role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Previous communication: Presented as an oral presentation at the British Society of Endovascular Therapy (BSET) 2019 Annual Conference (Wotton-under-Edge, United Kingdom, 27th-28th June 2019) and awarded the ‘BSET Peripheral Prize’. Presented as an oral presentation in the ‘PAD Scientific Session’ at the 33rd European Society of Vascular Surgery (ESVS) Annual Meeting (Hamburg, Germany, 24th-27th September 2019). Accepted for oral presentation at the Vascular Society of Great Britain and Ireland’s (VSGBI) 20319 Annual Scientific Meeting (Manchester, United Kingdom, 27th-29th November 2019)
Funding ATON, JD, LR, SD, HL, JSMH, SN and TP are funded through the George Davies Charitable Trust (Registered Charity Number: 1034818). RDS is part funded through this Trust. The funders had no role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.
Data Availability
Further details on methods, data and materials used will be considered upon email request.